Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy Updatesmclaren health planmclaren health plan Site of Care Policy Update | O…
    Ask Trek AI about this page
    Modifiedmclaren health planPolicy N/A

    Specialty Care Medication Site of Care/Infusible Updated Drug List

    Customize your policy alerts

    Sign up for all mclaren health plan policy alerts

    Know when mclaren health plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines McLaren Health Plan's Site of Care requirements for certain specialty injectable and infusible medications for Community and McLaren Health Advantage members, including reimbursement exclusions for hospital outpatient infusion centers and potential preauthorization requirements.

    Policy Summary
    Payermclaren health plan
    PolicySpecialty Care Medication Site of Care/Infusible Updated Drug List
    Policy CodePolicy N/A
    Change TypeUpdated drug/code listclarified reimbursement and authorization requirements
    Effective DateAug 1, 2024
    Last ReviewAug 1, 2024
    Next Review DateN/A
    Key ActionProviders must submit an authorization request with supporting documentation to request an exception when a member cannot receive medications in the home or non-hospital infusion center due to contraindications.
    SourceLink
    POLICY UPDATE CHANGES

    Effective August 1, 2024, McLaren Health Plan updated the list of injectable/infusible medication codes subject to Site of Care requirements.

    Infusions for the listed medications are excluded from reimbursement when administered in a hospital outpatient infusion center; they must be administered in a non-facility setting (home or non-hospital affiliated infusion center).

    Medications on the list may still require preauthorization regardless of site of care; refer to the Service Codes Requiring Preauthorization list on the MHP website.

    Exceptions to the site-of-care requirement may be made when a physician submits an authorization request with supporting documentation indicating contraindications to home or non-hospital infusion.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Multiplecodes updated on list
    08/01/2024effective date
    Community & Advantagelines of business
    Excludedhospital infusion stance

    Site of Care Coverage Criteria

    Site of Care coverage criteria

    Coverage and reimbursement conditions for listed injectable/infusible medications:

    Drugs enumerated on the updated Site of Care list must be administered in a non-facility setting (for example, the member's home or a non-hospital affiliated infusion center) to be eligible for reimbursement.
    Infusions of listed drugs administered in a hospital outpatient infusion center are excluded from reimbursement.
    Medications on the list may require preauthorization regardless of site of care; providers must consult the Service Codes Requiring Preauthorization list on the McLaren Health Plan website (Providers > Medical Management and Authorization > Referral and Authorization Guidelines).

    Exception pathway

    • A physician may submit an authorization request requesting an exception.
    • The request must include supporting clinical documentation indicating contraindications to administration in the home or a non-hospital infusion center; McLaren Health Plan will review for possible approval.
    • Prescribers and members will receive advance notification if they are impacted by these Site of Care requirements.
    For questions, contact your Provider Relations Representative at (888) 327-0761 (TTY: 711).

    Operational contact

    Affected Codes and Reimbursement Notes

    Sample HCPCS/J/Q codes from updated listHCPCS
    J3262Acterma
    J1560Acterma
    J0256Alpha 1 Proteinase Inhibitor
    J0172Aduhelm
    J0596Ruconest
    Q5104Renflexis
    J1554Acseniv
    J1426Amondys 45
    J0225Amvuttra
    J1602Amvuttra
    Additional listed HCPCS/J/Q codes (from same updated list)HCPCS
    Q5121Avsola
    J1559Avsola
    J2327Avsola
    J0490Benlysta
    J1575Benlysta
    J1300Benlysta
    J0597Berinert
    J3245Berinert
    J2326Berinert
    J1556Bivigam
    Further listed HCPCS/J/Q codes (continued)HCPCS
    J9173Bivigam
    J3357Bivigam
    J2329Briumvi
    J1599Briumvi
    J3358Briumvi
    J0741Cabenuva
    Q5103Cabenuva
    J3241Cabenuva
    J9272Carimune
    J2356Carimune
    Additional continued HCPCS/J/Q codesHCPCS
    J1786Cerezyme
    J1290Cerezyme
    J1746Cerezyme
    J0717Cimzia
    J9271Cimzia
    J2323Cimzia
    J0598Cinryze
    J0202Cinryze
    J1303Cinryze
    J0584Crysvita
    Additional continued HCPCS/J/Q codes (from chunk 4-5)HCPCS
    J0221Crysvita
    J1322Crysvita
    J1743Elaprase
    J3398Elaprase
    J3385Elaprase
    J3060Elelyso
    J1428Elelyso
    J3032Elelyso
    J1302Enjaymo
    J0219Enjaymo
    Site of Care reimbursement exclusion
    Reimbursement exclusionInfusions for drugs on the updated Site of Care list are excluded from reimbursement when administered in a hospital outpatient infusion center.
    Affected servicesInjectable or infusible drugs enumerated on the McLaren Health Plan Site of Care list (see updated drug/code list).
    Effective date of list updateEffective August 1, 2024 (updated enumerated drug/code list appended).

    Authorization, Exceptions, and Provider Guidance

    Prior Authorization

    Preauthorization may still be required; see Service Codes Requiring Preauthorization

    Medications on the Site of Care list may require preauthorization regardless of the site where they are administered. Providers must consult the Service Codes Requiring Preauthorization list on the McLaren Health Plan website for preauthorization requirements and instructions.

    • Reference: McLarenHealthPlan.org > Providers > Medical Management and Authorization > Referral and Authorization Guidelines (Service Codes Requiring Preauthorization list).
    Prior Authorization

    Submit physician authorization request with supporting documentation for exceptions

    A physician may submit an authorization request with supporting clinical documentation to request an exception when a member cannot safely receive the medication in the home or a non-hospital infusion center; MHP will review the documentation for possible exception approval.

    • Include supporting documentation that indicates the contraindication to home or non-hospital infusion.
    • Prescribers and members will receive advance notification if impacted by Site of Care requirements.

    Key Definitions

    Non-facility setting — definition and examples
    DefinitionNon-facility setting: settings such as the patient's home or a non-hospital affiliated infusion center where listed injectable/infusible drugs must be administered per MHP Site of Care guidelines.
    ExamplesPatient's home; non-hospital affiliated infusion center.
    PurposeAdministration in these settings is required for reimbursement of listed drugs under MHP Site of Care policy.
    Hospital outpatient infusion center — definition and reimbursement exclusion note
    DefinitionHospital outpatient infusion center: a hospital-affiliated outpatient infusion setting.
    Reimbursement noteInfusions of listed medications administered in a hospital outpatient infusion center are excluded from reimbursement under MHP Site of Care guidelines.
    Policy Summary
    Payermclaren health plan
    PolicySpecialty Care Medication Site of Care/Infusible Updated Drug List
    Policy CodePolicy N/A
    Change TypeUpdated drug/code listclarified reimbursement and authorization requirements
    Effective DateAug 1, 2024
    Last ReviewAug 1, 2024
    Next Review DateN/A
    Key ActionProviders must submit an authorization request with supporting documentation to request an exception when a member cannot receive medications in the home or non-hospital infusion center due to contraindications.
    SourceLink
    On This Page
    Site of Care Coverage CriteriaAffected Codes and Reimbursement NotesAuthorization, Exceptions, and Provider GuidanceKey Definitions
  1. For questions, contact Provider Relations at (888) 327-0761 (TTY: 711).
  2. Implication for providersIf administration occurs in a hospital outpatient infusion center, the listed drug infusion will not be reimbursed unless an approved exception exists via authorization process.